Literature DB >> 29433965

HIV preexposure prophylaxis: An essential, safe and effective prevention tool for sexual health.

M Siguier1, J-M Molina2.   

Abstract

Preexposure prophylaxis of HIV with antiretroviral drugs is a prevention tool available in France since 2016, combined with the prevention methods already used (condoms, post-exposure treatment, rapid treatment of diagnosed HIV infections, etc.). It is targeted at populations at high risk of HIV infection, especially men who have sex with men, for whom traditional prevention methods are insufficient. We collected clinical research data, which resulted in the launch of preexposure prophylaxis in the United States and then elsewhere in the world, safety, tolerability and cost data, as well as ongoing research data (new molecules/methods of administration). We also provided an update of its use in France.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  HIV; PrEP; Prophylaxie; Prophylaxis; VIH

Mesh:

Substances:

Year:  2018        PMID: 29433965     DOI: 10.1016/j.medmal.2018.01.009

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  3 in total

1.  HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost-Utility Analysis.

Authors:  Paulina Quirola-Amores; Pablo Espinosa; Sebastian Oleas; Isabel Hernandez; Aquiles R Henriquez; Enrique Teran
Journal:  Front Public Health       Date:  2022-06-17

2.  Knowledge, Attitudes and Practices Regarding Pre-Exposure Prophylaxis (PrEP) in a Sample of Italian Men Who Have SEX with MEN (MSM).

Authors:  Gianluca Voglino; Maria Rosaria Gualano; Stefano Rousset; Pietro Forghieri; Isabella Fraire; Fabrizio Bert; Roberta Siliquini
Journal:  Int J Environ Res Public Health       Date:  2021-04-29       Impact factor: 3.390

3.  Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021.

Authors:  Sophie Billioti de Gage; David Desplas; Rosemary Dray-Spira
Journal:  Lancet Reg Health Eur       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.